Ketamine-Based Antidepression Nasal Spray Gets FDA Thumbs Up The FDA announced on Tuesday that esketamine has been approved for people with treatment-resistant depression. The drug developed by Janssen Pharmaceuticals Inc. can offer quick relief from symptoms for patients living with the mood disorder. by Diane Samson
Healthy Living/Wellness Light Therapy Also Effective Treatment For All Depression Not Just Winter Blues by Alyssa Navarro
Healthy Living/Wellness A single dose of antidepressant can alter how your brain works by Christian Bautista